Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice
Science Advances · 25.10.2024 · 10 (43)
DOI: 10.1126/sciadv.ado9311 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 25.10.2024. Verfasst von Xiaoju Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Medicine, University of Louisville, Louisville, KY 40202, USA. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Carcinoma, Hepatocellular, Liver Neoplasms, Macrophages. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Metabolic dysfunction–associated steatohepatitis is well accepted as a potential precursor of hepatocellular carcinoma. Previously, we reported that fibroblast growth factor 21 (FGF21) revealed a novel anti-inflammatory activity via inhibiting the TLR4–IL-17A signaling, which could be a potential anticarcinogenetic mechanism to prevent to MASH-HCC transition. Here, we set out to determine whether FGF21 has a major impact on Kupffer cells’ (KCs) ability during MASH-HCC transition. We found aberrant hepatic FGF21 and KC pool in human MASH-HCC. Lack of FGF21 up-regulated ALOX15, which converted the oxidized fatty acids to induce excessive KC death and mobilization of monocyte-derived macrophages (MoMFs) for KC replacement. Lack of FGF21 oversupplied free fatty acids for sphingosine-1-phosphate (S1P) cascade synthesis to mediate MASH-HCC transition via S1P-YAP signaling and cross-talk between tumor cells and macrophages. In conclusion, lack of FGF21 accelerated MASH-HCC transition via the S1P-AP signaling. Compromised MoMFs could present as tumor-associated macrophage phenotype rendering tumor immune microenvironment for MASH-HCC transition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, School of Medicine, University of Louisville, Louisville, KY 40202, USA.
- Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun 130021, China.
- Department of Pathophysiology, Basic Medicine College, China Medical University, Shenyang 110122, China.
- Department of Hematology, The First Hospital of Jilin University, Changchun, Jilin, China.
- Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang 110022, China.
ORCID-Profile: Xiaoju Shi, Qianqian Zheng, Xingtong Wang, Wei Guo, Yonglin Gao, Emily Shore, Guoyue Lv, Yan Li
Förderung
- NIGMS NIH HHS
Zitieren
APA
Shi, X., Zheng, Q., Wang, X., Guo, W., Lin, Z., Gao, Y., Shore, E., Martin, R. C., Lv, G., & Li, Y. (2024). Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice. Science Advances, 10(43). https://doi.org/10.1126/sciadv.ado9311
Vancouver
Shi X, Zheng Q, Wang X, Guo W, Lin Z, Gao Y, et al. Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice. Science Advances. 2024;10(43). doi:10.1126/sciadv.ado9311
BibTeX
@article{Shi2024,
author = {Shi, Xiaoju and Zheng, Qianqian and Wang, Xingtong and Guo, Wei and Lin, Ziqi and Gao, Yonglin and Shore, Emily and Martin, Robert C and Lv, Guoyue and Li, Yan},
title = {Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {43},
doi = {10.1126/sciadv.ado9311}
}
EUVIMED